Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 53,200 shares at $2.68 ($141K) on 2023-08-01, disclosed to the SEC on 2023-08-03.
Scheduled sale ($141k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.68 | 19,736 | $53K | 37.4% |
| 2 | $2.68 | 19,736 | $53K | 37.4% |
| 3 | $2.59 | 13,728 | $36K | 25.2% |
| Total | $2.66 avg | 53,200 | $141K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-05 | $881K | — | Filing → |
| VRNA | SELL | 2025-05-01 | $618K | — | Filing → |
| VRNA | SELL | 2025-03-13 | $1.3M | — | Filing → |